Carlsmed (CARL) Equity Ratio (2024 - 2026)

Carlsmed has reported Equity Ratio for 3 years, with the latest figure at 0.78 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio changed N/A year-over-year to 0.78; the trailing twelve-month figure through Mar 2026 stood at 0.78 (changed N/A YoY), and the FY2025 full-year result was 0.76, up 155.75% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.78, up from 0.76 in the prior quarter.
• The five-year high for Equity Ratio was 0.79 in Q3 2025, with the low at 1.56 in Q2 2025.
• Historically, Equity Ratio has averaged 0.12 across 3 years, with a median of 0.76 in 2025.
• The largest YoY upside for Equity Ratio was 155.75% in 2025 against a maximum downside of 155.75% in 2025.
• Carlsmed's Equity Ratio stood at 1.36 in 2024, then surged by 155.75% to 0.76 in 2025, then grew by 2.22% to 0.78 in 2026.
• The last three Equity Ratio figures came in at 0.78 (Q1 2026), 0.76 (Q4 2025), and 0.79 (Q3 2025), per Business Quant data.